Literature DB >> 1846885

Enhanced replication of herpes simplex virus type 1 in human cells.

C S Miller1, K O Smith.   

Abstract

The effects of DNA-damaging agents on the replication of herpes simplex virus type 1 (HSV-1) were assessed in vitro. Monolayers of human lung fibroblast cell lines were exposed to DNA-damaging agents (methyl methanesulfonate [MMS], methyl methanethiosulfonate [MMTS], ultraviolet light [UV], or gamma radiation [GR]) at specific intervals, before or after inoculation with low levels of HSV-1. The ability of cell monolayers to support HSV-1 replication was measured by direct plaque assay and was compared with that of untreated control samples. In this system, monolayers of different cell lines infected with identical HSV-1 strains demonstrated dissimilar levels of recovery of the infectious virus. Exposure of DNA-repair-competent cell cultures to DNA-damaging agents produced time-dependent enhanced virus replication. Treatment with agent before virus inoculation significantly (p less than 0.025) increased the number of plaques by 10 to 68%, compared with untreated control cultures, while treatment with agent after virus adsorption significantly increased (p less than 0.025) the number of plaques by 7 to 15%. In a parallel series of experiments, cells deficient in DNA repair (xeroderma pigmentosum) failed to support enhanced virus replication. These results suggest that after exposure to DNA-damaging agents, fibroblasts competent in DNA repair amplify the replication of HSV-1, and that DNA-repair mechanisms that act on a variety of chromosomal lesions may be involved in the repair and biological activation of HSV-1 genomes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846885     DOI: 10.1177/00220345910700020301

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  6 in total

1.  Ionizing radiation does not alter the antitumor activity of herpes simplex virus vector G207 in subcutaneous tumor models of human and murine prostate cancer.

Authors:  T J Jorgensen; S Katz; E K Wittmack; S Varghese; T Todo; S D Rabkin; R L Martuza
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

2.  Antiviral effects of blackberry extract against herpes simplex virus type 1.

Authors:  Robert J Danaher; Chunmei Wang; Jin Dai; Russell J Mumper; Craig S Miller
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-09

3.  Herpesvirus quiescence in neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway.

Authors:  R J Danaher; A D Savells-Arb; S A Black ; R J Jacob; C S Miller
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

4.  Early nucleosome deposition on, and replication of, HSV DNA requires cell factor PCNA.

Authors:  Iryna Sanders; Mark Boyer; Nigel W Fraser
Journal:  J Neurovirol       Date:  2015-02-12       Impact factor: 2.643

5.  Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice.

Authors:  Fei Ma; Chunmei Wang; William E Yoder; Karin N Westlund; Charles R Carlson; Craig S Miller; Robert J Danaher
Journal:  J Oral Facial Pain Headache       Date:  2016

6.  Herpesvirus quiescence in neuronal cells. V: forskolin-responsiveness of the herpes simplex virus type 1 alpha0 promoter and contribution of the putative cAMP response element.

Authors:  Robert J Danaher; Robert J Jacob; Craig S Miller
Journal:  J Neurovirol       Date:  2003-08       Impact factor: 2.643

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.